Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine for delirium in ICU patients with COVID-19
IRCT20210425051075N2Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in delirium comparing Clonidine with Placebo (2 arms). Primary endpoints: Effect of clonidine on delirium symptoms, Clonidine safety: blood pressure lowering and 1 more. Started Oct 2021; status: completed.
02
Drugs
clonidine
03
Conditions
delirium
Beyond the preview
Go deeper on IRCT20210425051075N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210425051075N2.